Home LiteratureArticle Details
PMID: 17284712 Published · ppublish English News

With targeted drugs, chronic myelogenous leukemia therapy may follow HIV's model.

Journal of the National Cancer Institute ·Vol. 99 ·No. 3 ·2007-02-07 ·Pages 192-4

Tuma RS

Abstract

暂无摘要

MeSH Terms
Antineoplastic Agents/administration & dosage,economics,pharmacology Antiretroviral Therapy, Highly Active/economics Benzamides Dasatinib Drug Administration Schedule Drug Costs Fusion Proteins, bcr-abl/genetics HIV Infections/drug therapy Humans Imatinib Mesylate Isoleucine Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy,economics,genetics Mutation Piperazines/economics,pharmacology Protein Kinase Inhibitors/economics,pharmacology Pyrimidines/economics,pharmacology Thiazoles/economics,pharmacology Threonine United States
Chemicals
Antineoplastic Agents Benzamides Piperazines Protein Kinase Inhibitors Pyrimidines Thiazoles Isoleucine Threonine VX680 Imatinib Mesylate Fusion Proteins, bcr-abl Dasatinib
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Tuma Rabiya S
Article Info
Journal
Journal of the National Cancer Institute
Abbr.
J Natl Cancer Inst
ISSN
1460-2105
Published
2007-02-07
Pages
192-4
Language
English
Region
United States
NLM ID
7503089
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com